Profile
Andrew R.
Miksztal worked as an Associate Director-Pharmaceutical Analysis at Oread Laboratories, Inc. from 1996 to 2000.
Prior to that, he worked as a Scientist-Preformulation & Pharmaceutical Analysis at Syntex Corp.
from 1987 to 1995.
He also worked as a Senior Scientist-Pharmaceutical Research at Roche Palo Alto LLC in 1995 and 1996.
Dr. Miksztal earned a doctorate degree from Rutgers State University of New Jersey.
Former positions of Andrew R. Miksztal
| Companies | Position | End |
|---|---|---|
| Oread Laboratories, Inc. | Corporate Officer/Principal | 01/01/2000 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | 01/01/1996 |
| Syntex Corp. | Chief Tech/Sci/R&D Officer | 01/01/1995 |
Training of Andrew R. Miksztal
| Rutgers State University of New Jersey | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| Oread Laboratories, Inc. | |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
| Syntex Corp. | Health Technology |
- Stock Market
- Insiders
- Andrew R. Miksztal
